Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Hurley

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Medical Journal of Australia|September 17, 1990
Screening: the need for a population registerS F Hurley
Pharmacoeconomics|February 8, 1992
Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapyS F Hurley
The Medical Journal of Australia|January 21, 1991
Personal costs incurred by women attending a mammographic screening programmeS F Hurley, P M Livingston
Tobacco Control|August 23, 2008
Cost-effectiveness of the Australian National Tobacco CampaignS F Hurley, J P Matthews
The Medical Journal of Australia|July 20, 1987
Drug-bone marrow interactionsC G Berbatis, S F Hurley
The Medical Journal of Australia|September 18, 1989
Drug-coding systems: why so many?S F Hurley, J J McNeil
Epidemiologic Reviews|January 1, 1992
The benefits and risks of mammographic screening for breast cancerS F Hurley, J M Kaldor
Clinical Pharmacokinetics|May 1, 1988
A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosageS F Hurley, J J McNeil
Lancet (London, England)|June 21, 1997
Effectiveness of needle-exchange programmes for prevention of HIV infectionS F Hurley, D J Jolley, J M Kaldor
Community Health Studies|January 1, 1988
Sources of Australian pharmacoepidemiology dataS F Hurley, J J McNeil, C G Berbatis
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Medical Journal of Australia|September 17, 1990
Screening: the need for a population registerS F Hurley
Pharmacoeconomics|February 8, 1992
Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapyS F Hurley
The Medical Journal of Australia|January 21, 1991
Personal costs incurred by women attending a mammographic screening programmeS F Hurley, P M Livingston
Tobacco Control|August 23, 2008
Cost-effectiveness of the Australian National Tobacco CampaignS F Hurley, J P Matthews
The Medical Journal of Australia|July 20, 1987
Drug-bone marrow interactionsC G Berbatis, S F Hurley
The Medical Journal of Australia|September 18, 1989
Drug-coding systems: why so many?S F Hurley, J J McNeil
Epidemiologic Reviews|January 1, 1992
The benefits and risks of mammographic screening for breast cancerS F Hurley, J M Kaldor
Clinical Pharmacokinetics|May 1, 1988
A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosageS F Hurley, J J McNeil
Lancet (London, England)|June 21, 1997
Effectiveness of needle-exchange programmes for prevention of HIV infectionS F Hurley, D J Jolley, J M Kaldor
Community Health Studies|January 1, 1988
Sources of Australian pharmacoepidemiology dataS F Hurley, J J McNeil, C G Berbatis
Pageof 4